Export 12 results:
Filters: Keyword is tau Proteins  [Clear All Filters]
2017
Tracy TE, Gan L.  2017.  Acetylated tau in Alzheimer's disease: An instigator of synaptic dysfunction underlying memory loss: Increased levels of acetylated tau blocks the postsynaptic signaling required for plasticity and promotes memory deficits associated with tauopathy.. Bioessays. 39(4)
Carlomagno Y, Chung D-EChloe, Yue M, Castanedes-Casey M, Madden BJ, Dunmore J, Tong J, DeTure M, Dickson DW, Petrucelli L et al..  2017.  An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.. J Biol Chem. 292(37):15277-15286.
Spina S, Schonhaut DR, Boeve BF, Seeley WW, Ossenkoppele R, O'Neil JP, Lazaris A, Rosen HJ, Boxer AL, Perry DC et al..  2017.  Frontotemporal dementia with the V337M mutation: Tau-PET and pathology correlations.. Neurology. 88(8):758-766.
Chen J, Yu J-T, Wojta K, Wang H-F, Zetterberg H, Blennow K, Yokoyama JS, Weiner MW, Kramer JH, Rosen H et al..  2017.  Genome-wide association study identifies locus influencing human plasma tau levels.. Neurology. 88(7):669-676.
Boselli M, Lee B-H, Robert J, Prado MA, Min S-W, Cheng C, M Silva C, Seong C, Elsasser S, Hatle KM et al..  2017.  An inhibitor of the proteasomal deubiquitinating enzyme USP14 induces tau elimination in cultured neurons.. J Biol Chem. 292(47):19209-19225.
Goetzl EJ, Miller BL.  2017.  Multicellular hypothesis for the pathogenesis of Alzheimer's disease.. FASEB J. 31(5):1792-1795.
Wang C, Ward ME, Chen R, Liu K, Tracy TE, Chen X, Xie M, Sohn PDongmin, Ludwig C, Meyer-Franke A et al..  2017.  Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening.. Stem Cell Reports. 9(4):1221-1233.
Yokoyama JS, Karch CM, Fan CC, Bonham LW, Kouri N, Ross OA, Rademakers R, Kim J, Wang Y, Höglinger GU et al..  2017.  Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia.. Acta Neuropathol. 133(5):825-837.